期刊文献+

人体肿瘤PDX移植模型的优与劣 被引量:8

The Advantages and Disadvantages of Human PDX Transplantation Model
下载PDF
导出
摘要 介绍人体肿瘤移植(patient-derived tumor xenograft model,PDX)模型的基本特征和在生物医学研究中的应用;比较该类模型应用于肿瘤研究的优点和存在的问题。目的是正确应用PDX模型开展研究工作,分析相应的实验结果,加快肿瘤药物研发进程。 The basic features and application in biomedical research of PDX models( patient-derived tumor xenograft) are introduced. We compare the advantages of this model applied to cancer research and the existing problems. The purpose is to use PDTX models to carry out the research work and analyse experimental results correctly,which can speed up the process of cancer drug development.
出处 《实验动物科学》 2015年第5期59-62,共4页 Laboratory Animal Science
基金 国家自然科学基金(No.31572340) 军队实验动物专项课题(No.SYDW2014-002)
关键词 人体肿瘤异种移植 药物研究 模型 免疫缺陷小鼠 patient derived tumor xenografts(PDX) drug research model immunodeficiency mouse
  • 相关文献

参考文献27

  • 1Monsma D J,Cherba D M,Eugster E E,et al.Melanoma patient derived xenografts acquire distinct Vemurafenib resistance mechanisms. American journal of cancer research . 2015
  • 2Qianjun Zhou,John Facciponte,Min Jin,Qiang Shen,Qiang Lin.??Humanized NOD-SCID IL2rg –/– mice as a preclinical model for cancer research and its potential use for individualized cancer therapies(J)Cancer Letters . 2013
  • 3Massimo Moro,Giulia Bertolini,Monica Tortoreto,Ugo Pastorino,Gabriella Sozzi,Luca Roz,Andrea Vecchione.??Patient-Derived Xenografts of Non Small Cell Lung Cancer: Resurgence of an Old Model for Investigation of Modern Concepts of Tailored Therapy and Cancer Stem Cells(J)Journal of Biomedicine and Biotechnology . 2012
  • 4Torphy RJ,Tignanelli CJ,Kamande JW.et al.Circulating tumor cells as a biomarker of response to treatment in patient-derived xenograft mouse models of pancreatic adenocarcinoma. PLo S One . 2014
  • 5Shultz Leonard D,Saito Yoriko,Najima Yuho,Tanaka Satoshi,Ochi Toshiki,Tomizawa Mariko,Doi Takehiko,Sone Akiko,Suzuki Nahoko,Fujiwara Hiroshi,Yasukawa Masaki,Ishikawa Fumihiko.Generation of functional human T-cell subsets with HLA-restricted immune responses in HLA class I expressing NOD/SCID/IL2r gamma(null) humanized mice. Proceedings of the National Academy of Sciences of the United States of America . 2010
  • 6Dobbin Z C,Katre A A,Steg A D,et al.Using heterogeneity of the patient-derived xenograft model to identify the chemoresistant population in ovarian cancer. Oncotarget . 2014
  • 7Jung J.Human tumor xenograft models for preclinical assessment of anticancer drug development. Toxicological research . 2014
  • 8Siolas D,Hannon GJ.Patient-derived tumor xenografts:transforming clinical samples into mouse models. Cancer Research . 2013
  • 9Kung P P,Martinez R,Zhu Z,et al.Chemogenetic evaluation of the mitotic kinesin CENP-E reveals a critical role in triplenegative breast cancer. Molecular Cancer Therapeutics . 2014
  • 10Bockhorn J,Prat A,Chang Y-F, et al.Differentiation and loss of malignancy of spontaneous pulmonary metastases in patient-derived breast cancer models (PDXs). Cancer Research . 2014

二级参考文献70

共引文献14

同被引文献51

引证文献8

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部